GLP 1 News and Research

RSS
New Fragment Screening Platform from Selcia

New Fragment Screening Platform from Selcia

European CHMP recommends Merck's JANUVIA and JANUMET as add-on to insulin

European CHMP recommends Merck's JANUVIA and JANUMET as add-on to insulin

BCLI collaborates with HBI to complete pre-clinical safety experiments

BCLI collaborates with HBI to complete pre-clinical safety experiments

Clinical Logistics partners with a GLP compliant laboratory

Clinical Logistics partners with a GLP compliant laboratory

Oral GLP-1 Analog approved for human clinical trial

Oral GLP-1 Analog approved for human clinical trial

Nanoemulsion-based adjuvant increases immunity and cross protection against influenza

Nanoemulsion-based adjuvant increases immunity and cross protection against influenza

Grant awarded to two researchers to study the role of GLP-1 in people at risk for or with diabetes

Grant awarded to two researchers to study the role of GLP-1 in people at risk for or with diabetes

Paper discussing the mechanism of the selective TGR5 agonist INT-777 published in Cell Metabolism

Paper discussing the mechanism of the selective TGR5 agonist INT-777 published in Cell Metabolism

Synco Bio to manufacture Versartis type 2 diabetes drug candidate

Synco Bio to manufacture Versartis type 2 diabetes drug candidate

First batch of cancer vaccine from Cancer Vaccine Collaborative goes into trial

First batch of cancer vaccine from Cancer Vaccine Collaborative goes into trial

Expression Analysis launches new look

Expression Analysis launches new look

NDA for Exenatide once weekly accepted for FDA review

NDA for Exenatide once weekly accepted for FDA review

Novel diabetes treatment Syncria (albiglutide) improves glucose control and reduces weight

Novel diabetes treatment Syncria (albiglutide) improves glucose control and reduces weight

Why low GI diet makes you feel full

Why low GI diet makes you feel full

GlaxoSmithKline starts phase III trial of Syncria (albiglutide) type 2 diabetes medication

GlaxoSmithKline starts phase III trial of Syncria (albiglutide) type 2 diabetes medication

Amylin, Lilly update on FDA review of Byetta (exenatide) injection monotherapy submission

Amylin, Lilly update on FDA review of Byetta (exenatide) injection monotherapy submission

Anadys Pharmaceuticals receives fast track for ANA598 treatment of chronic hepatitis C virus

Anadys Pharmaceuticals receives fast track for ANA598 treatment of chronic hepatitis C virus

FDA continues review of Takeda's NDA for Alogliptin

FDA continues review of Takeda's NDA for Alogliptin

Once a week treatment for type 2 diabetes in the pipeline

Once a week treatment for type 2 diabetes in the pipeline

Advances in the management of diabetes mellitus

Advances in the management of diabetes mellitus